0001237831-17-000027.txt : 20170609 0001237831-17-000027.hdr.sgml : 20170609 20170609161648 ACCESSION NUMBER: 0001237831-17-000027 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170607 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20170609 DATE AS OF CHANGE: 20170609 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBUS MEDICAL INC CENTRAL INDEX KEY: 0001237831 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043744954 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35621 FILM NUMBER: 17903133 BUSINESS ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 BUSINESS PHONE: 610-930-1800 MAIL ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 8-K 1 gmed69178k.htm 8-K Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_____________

FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): June 7, 2017

GLOBUS MEDICAL, INC.
(Exact name of Registrant as specified in its charter)

   Delaware
   (State or Other
     Jurisdiction of
     Incorporation)

   001-35621
   (Commission File
     Number)

   04-3744954
   (I.R.S. Employer
     Identification No.)

 
2560 General Armistead Avenue
 
 
 
 
Audubon, PA
 
 
 
19403
 
 
(Address of Principal Executive Offices)
 
 
(Zip Code)

Registrant's telephone number, including area code: (610) 930-1800

____________Not Applicable_______________
(Former Name or Former Address, if Changed Since Last Report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2. below):
o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 5.07. Submission of Matters to a Vote of Security Holders.

The Annual Meeting of Stockholders (the “Annual Meeting”) of Globus Medical, Inc. (the “Company”) was held on June 7, 2017. At the Annual Meeting, the stockholders voted on the following three proposals and cast their votes as described below.


Proposal 1

The individuals listed below were each elected at the Annual Meeting to serve a three-year term on the Company’s Board of Directors.

Nominee
For
Against
Abstain
Broker Non-Vote
David M. Demski
268,811,788
27,072,155
402,650
9,182,411
Kurt C. Wheeler
295,269,054
613,973
403,566
9,182,411


Proposal 2

Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017. This proposal was approved.

For
Against
Abstain
Broker Non-Vote
305,039,537
25,110
404,357
0


Proposal 3

A non-binding advisory vote to approve the compensation of the Company’s named executive officers, as described in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission. This proposal was approved.

For
Against
Abstain
Broker Non-Vote
292,523,308
3,343,957
419,328
9,182,411















SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


GLOBUS MEDICAL, INC.
(Registrant)


/s/ ERIC IAN SCHWARTZ
Eric Ian Schwartz
Senior Vice President, General Counsel
Dated: June 9, 2017